EVER Pharma acquires Amneal Deutschland GmbH and extends its commercial presence in Europe. Amneal Deutschland already distributes several EVER Pharma products in Germany and is a strongly established player in the German hospital market. The acquired entity will be rebranded to EVER Pharma GmbH.
“We are pleased to establish another EVER affiliate in one of the key European markets in line with our strategy of establishing our own business presence in core markets.” added Julia Hillebrand, Managing Director and Owner.
About EVER Pharma:
EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production and commercialization of products in the areas of neurology, critical care, anesthesia and oncology. EVER Pharma markets in over 70 countries through wholly owned affiliates and distribution partners.